• Quantitative analysis used to identify hepatitis B biomarker
    A potential biomarker for hepatitis B has been discovered through the use of quantitative analysis.

Electrophoretic Separations

Quantitative analysis used to identify hepatitis B biomarker

Jun 09 2011

The systematic identification of specific proteins which are key factors in disease progression through quantitative analysis is essential to understanding illnesses.

In a study published by the Virology Journal, a team of scientists aimed to identify the proteins specific to hepatitis B virus (HBV) induced hepatitis.

The team claimed that although many proteins have been found that are known to have an impact on hepatitis, the fact that no systematic protein screening has been documented is hindering the understanding and treatment of the disease.

As a result of the study they found, through two-dimensional electrophoresis (2-DE), peptide mass fingerprinting (PMF) analysis, that the expression level of alpha-1 antitrypsin (AAT) was significantly elevated in serum samples from patients with severe chronic hepatitis.

Furthermore, the scientists discovered that AAT is with highest expression in normal tissue and cells, and lowest in hepatic carcinoma and severe chronic hepatitis tissues and cells, suggesting the specific secretion of AAT from tissues and cells to serum.

The team concluded that AAT, therefore, has the potential to act as a biomarker for hepatitis B in diagnosis, aiding treatment.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

View all events